Nestor MS - Search Results

1

Novel injectable polypeptide nanoparticle encapsulated siRNA targeting TGF-β1 and COX-2 for localized fat reduction I: Preclinical in vitro and animal models.

Nestor MS, Hetzel J, Awad N, Bhupalam V, Lu P, Molyneaux M. Nestor MS, et al. J Cosmet Dermatol. 2024 Oct;23(10):3133-3143. doi: 10.1111/jocd.16535. Epub 2024 Aug 21. J Cosmet Dermatol. 2024. PMID: 39166716

2

"Masking" our emotions: Botulinum toxin, facial expression, and well-being in the age of COVID-19.

Nestor MS, Fischer DL, Arnold D. Nestor MS, et al. J Cosmet Dermatol. 2020 Sep;19(9):2154-2160. doi: 10.1111/jocd.13569. Epub 2020 Jul 12. J Cosmet Dermatol. 2020. PMID: 32592268 Free PMC article. Review.

3

Botulinum toxin complications in registered and off-label aesthetic indications.

Landau M, Nestor MS, de Almeida AT, Al-Niaimi F. Landau M, et al. Among authors: nestor ms. J Cosmet Dermatol. 2020 Oct;19(10):2484-2490. doi: 10.1111/jocd.13667. Epub 2020 Aug 28. J Cosmet Dermatol. 2020. PMID: 32857479 Review.

4

The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II.

Nestor MS, Arnold D, Fischer DL. Nestor MS, et al. J Cosmet Dermatol. 2020 Nov;19(11):2785-2804. doi: 10.1111/jocd.13702. Epub 2020 Sep 16. J Cosmet Dermatol. 2020. PMID: 32866999 Free PMC article. Review.

5

Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options.

Nestor MS, Han H, Gade A, Fischer D, Saban Y, Polselli R. Nestor MS, et al. J Cosmet Dermatol. 2021 Oct;20(10):3133-3146. doi: 10.1111/jocd.14361. Epub 2021 Aug 11. J Cosmet Dermatol. 2021. PMID: 34378298 Free PMC article. Review.

6

Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.

Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Nestor MS, et al. J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6. J Cosmet Dermatol. 2021. PMID: 34741573 Free PMC article. Review.

7

Safety and Efficacy of TGF-β1/COX-2 Silencing Therapeutic in Adults With Cutaneous Squamous Cell Carcinoma In Situ.

Nestor M, Berman B, Lu P, Molyneaux M. Nestor M, et al. J Drugs Dermatol. 2022 May 1;21(5):472-477. doi: 10.36849/JDD.6384. J Drugs Dermatol. 2022. PMID: 35533033

8

Safety and effectiveness of nano-pulse stimulation™ technology to treat acne vulgaris of the back.

Katz BE, Nestor MS, Nuccitelli R, Johnston LJ, Knape WA. Katz BE, et al. Among authors: nestor ms. J Cosmet Dermatol. 2023 May;22(5):1545-1553. doi: 10.1111/jocd.15633. Epub 2023 Jan 16. J Cosmet Dermatol. 2023. PMID: 36645338

9

Evaluating the safety and efficacy of aminolevulinic acid 20% topical solution activated by pulsed dye laser and blue light in the treatment of facial cutaneous squamous cell carcinoma in situ.

Nestor MS, Han H, Ceci FM, Lawson A, Gade A. Nestor MS, et al. J Cosmet Dermatol. 2023 Sep;22(9):2471-2475. doi: 10.1111/jocd.15886. Epub 2023 Jun 27. J Cosmet Dermatol. 2023. PMID: 37365973

10

Cryolipolysis in the United States-Review of the clinical data.

Hetzel J, Awad N, Bhupalam V, Nestor M. Hetzel J, et al. J Cosmet Dermatol. 2023 Nov;22 Suppl 3:8-14. doi: 10.1111/jocd.16029. J Cosmet Dermatol. 2023. PMID: 37988714 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters